Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomegaly | 5 | 2019 | 44 | 2.070 |
Why?
|
| Mast Cells | 11 | 2019 | 82 | 1.820 |
Why?
|
| TRPV Cation Channels | 7 | 2019 | 24 | 1.490 |
Why?
|
| Calcium Channels | 6 | 2015 | 73 | 1.360 |
Why?
|
| Heart Failure | 4 | 2019 | 302 | 0.910 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2019 | 20 | 0.630 |
Why?
|
| Calcium Signaling | 5 | 2015 | 107 | 0.630 |
Why?
|
| Acrylamides | 1 | 2019 | 14 | 0.630 |
Why?
|
| Transient Receptor Potential Channels | 3 | 2015 | 8 | 0.610 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 40 | 0.610 |
Why?
|
| Insulin | 2 | 2019 | 258 | 0.590 |
Why?
|
| Cannabinoids | 2 | 2018 | 73 | 0.570 |
Why?
|
| Disease Management | 1 | 2018 | 70 | 0.550 |
Why?
|
| Cytokinesis | 1 | 2015 | 10 | 0.450 |
Why?
|
| Ion Channels | 5 | 2007 | 74 | 0.420 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 200 | 0.410 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 30 | 0.400 |
Why?
|
| Cell Line | 12 | 2019 | 1410 | 0.390 |
Why?
|
| Pyrazines | 1 | 2012 | 32 | 0.380 |
Why?
|
| Cell Membrane | 4 | 2014 | 403 | 0.380 |
Why?
|
| Animals | 24 | 2020 | 16992 | 0.370 |
Why?
|
| Receptors, Drug | 4 | 2005 | 61 | 0.370 |
Why?
|
| Pyridines | 1 | 2012 | 139 | 0.360 |
Why?
|
| Calcium | 8 | 2015 | 491 | 0.350 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 48 | 0.350 |
Why?
|
| Aortic Diseases | 1 | 2011 | 34 | 0.350 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 749 | 0.350 |
Why?
|
| Muscle Proteins | 1 | 2011 | 51 | 0.350 |
Why?
|
| Receptors, IgE | 2 | 2014 | 22 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 1869 | 0.330 |
Why?
|
| Membrane Proteins | 5 | 2005 | 561 | 0.320 |
Why?
|
| Myocardium | 1 | 2011 | 263 | 0.290 |
Why?
|
| Chromogranins | 1 | 2008 | 5 | 0.290 |
Why?
|
| Chromogranin A | 1 | 2008 | 7 | 0.290 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 20 | 0.290 |
Why?
|
| Mice | 9 | 2020 | 6644 | 0.280 |
Why?
|
| Rats | 12 | 2019 | 3735 | 0.280 |
Why?
|
| Cell Communication | 1 | 2008 | 114 | 0.270 |
Why?
|
| Signal Transduction | 5 | 2019 | 2157 | 0.270 |
Why?
|
| Inositol Phosphates | 1 | 2005 | 8 | 0.230 |
Why?
|
| Ubiquitin | 1 | 2006 | 81 | 0.230 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2005 | 31 | 0.230 |
Why?
|
| ras Proteins | 1 | 2005 | 54 | 0.230 |
Why?
|
| Molecular Biology | 2 | 2015 | 47 | 0.220 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 74 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 223 | 0.210 |
Why?
|
| Kava | 2 | 2015 | 6 | 0.210 |
Why?
|
| Humans | 21 | 2020 | 43102 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 386 | 0.200 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2003 | 25 | 0.200 |
Why?
|
| Schools, Medical | 2 | 2015 | 208 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2019 | 570 | 0.180 |
Why?
|
| Mice, Knockout | 3 | 2020 | 1035 | 0.180 |
Why?
|
| Medicine, Traditional | 1 | 2020 | 23 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2014 | 883 | 0.170 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 281 | 0.160 |
Why?
|
| Plant Extracts | 2 | 2015 | 302 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 40 | 0.160 |
Why?
|
| Cardiolipins | 1 | 2019 | 12 | 0.160 |
Why?
|
| Endocytosis | 1 | 2020 | 118 | 0.150 |
Why?
|
| Glucose | 2 | 2019 | 244 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 652 | 0.150 |
Why?
|
| Oxygen | 1 | 2020 | 218 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2019 | 260 | 0.150 |
Why?
|
| Protein Binding | 4 | 2006 | 1082 | 0.140 |
Why?
|
| Astrocytes | 1 | 2020 | 244 | 0.140 |
Why?
|
| Male | 6 | 2019 | 23409 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1621 | 0.130 |
Why?
|
| Diptera | 1 | 2016 | 11 | 0.130 |
Why?
|
| Microcephaly | 1 | 2016 | 21 | 0.130 |
Why?
|
| Calcification, Physiologic | 1 | 2016 | 18 | 0.120 |
Why?
|
| Fluorescence | 1 | 2016 | 118 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 1596 | 0.120 |
Why?
|
| Anthozoa | 1 | 2016 | 23 | 0.120 |
Why?
|
| Larva | 1 | 2016 | 133 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 74 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 667 | 0.120 |
Why?
|
| Genome | 1 | 2016 | 149 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 143 | 0.110 |
Why?
|
| Cell Biology | 1 | 2014 | 13 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 306 | 0.110 |
Why?
|
| Mothers | 1 | 2016 | 215 | 0.110 |
Why?
|
| Phosphatidylserines | 1 | 2014 | 22 | 0.100 |
Why?
|
| Genomics | 1 | 2016 | 293 | 0.100 |
Why?
|
| Protein Transport | 3 | 2020 | 296 | 0.100 |
Why?
|
| Research | 1 | 2015 | 181 | 0.100 |
Why?
|
| Nanotubes, Carbon | 1 | 2014 | 87 | 0.100 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 20 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 95 | 0.090 |
Why?
|
| Lactones | 1 | 2012 | 23 | 0.090 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2011 | 12 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 83 | 0.090 |
Why?
|
| Echocardiography, Doppler | 1 | 2011 | 41 | 0.090 |
Why?
|
| Hawaii | 4 | 2016 | 2011 | 0.090 |
Why?
|
| Universities | 1 | 2015 | 559 | 0.090 |
Why?
|
| Phosphorylation | 4 | 2014 | 986 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 140 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 96 | 0.080 |
Why?
|
| TRPM Cation Channels | 3 | 2006 | 40 | 0.080 |
Why?
|
| Temperature | 2 | 2016 | 313 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2014 | 1271 | 0.070 |
Why?
|
| Leukemia, Mast-Cell | 1 | 2008 | 2 | 0.070 |
Why?
|
| Mastocytoma | 1 | 2008 | 4 | 0.070 |
Why?
|
| PC12 Cells | 1 | 2008 | 93 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2011 | 536 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1455 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2008 | 93 | 0.070 |
Why?
|
| Apoptosis | 2 | 2014 | 1568 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2005 | 66 | 0.070 |
Why?
|
| Membrane Potentials | 2 | 2006 | 222 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2016 | 760 | 0.070 |
Why?
|
| Biotransformation | 1 | 2007 | 69 | 0.060 |
Why?
|
| Serotonin | 2 | 2004 | 123 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 28 | 0.060 |
Why?
|
| Time Factors | 2 | 2016 | 1857 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 2676 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2005 | 10 | 0.060 |
Why?
|
| Prevalence | 2 | 2016 | 1612 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 219 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2006 | 152 | 0.060 |
Why?
|
| Antibodies | 1 | 2005 | 144 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2004 | 52 | 0.050 |
Why?
|
| Cations | 1 | 2004 | 50 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2005 | 127 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 296 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 197 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 196 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 82 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2003 | 63 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 1542 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 423 | 0.050 |
Why?
|
| Capsaicin | 1 | 2003 | 28 | 0.050 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2003 | 38 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 206 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 701 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 508 | 0.050 |
Why?
|
| Aggression | 1 | 2003 | 102 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 704 | 0.050 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2001 | 4 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 758 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2001 | 82 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2001 | 100 | 0.040 |
Why?
|
| Medicine | 1 | 2020 | 37 | 0.040 |
Why?
|
| Logistic Models | 1 | 2003 | 1009 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 125 | 0.040 |
Why?
|
| Phytotherapy | 1 | 2020 | 75 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1234 | 0.040 |
Why?
|
| Nerve Crush | 1 | 1998 | 4 | 0.040 |
Why?
|
| Ligands | 2 | 2015 | 388 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 13 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 1998 | 12 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 497 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 518 | 0.030 |
Why?
|
| Adult | 3 | 2016 | 13872 | 0.030 |
Why?
|
| Phylogeny | 2 | 2016 | 769 | 0.030 |
Why?
|
| Blood Banks | 1 | 2016 | 10 | 0.030 |
Why?
|
| Entomology | 1 | 2016 | 1 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2016 | 18 | 0.030 |
Why?
|
| Microscopy | 1 | 2016 | 35 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 86 | 0.030 |
Why?
|
| Calcium Carbonate | 1 | 2016 | 11 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2016 | 10 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1180 | 0.030 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2016 | 24 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2003 | 2544 | 0.030 |
Why?
|
| Photosynthesis | 1 | 2016 | 35 | 0.030 |
Why?
|
| Symbiosis | 1 | 2016 | 46 | 0.030 |
Why?
|
| Depression | 1 | 2003 | 863 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 259 | 0.030 |
Why?
|
| Anxiety | 1 | 2003 | 874 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 830 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 458 | 0.030 |
Why?
|
| Light | 1 | 2016 | 185 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 388 | 0.030 |
Why?
|
| Risk Factors | 1 | 2003 | 3994 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 172 | 0.030 |
Why?
|
| Hexosaminidase B | 1 | 2014 | 3 | 0.030 |
Why?
|
| Education, Graduate | 1 | 2014 | 31 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 228 | 0.030 |
Why?
|
| Clathrin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 53 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2014 | 74 | 0.030 |
Why?
|
| Fullerenes | 1 | 2014 | 31 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 102 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 210 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2014 | 114 | 0.030 |
Why?
|
| Female | 3 | 2016 | 24698 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 95 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 532 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 465 | 0.020 |
Why?
|
| TRPC Cation Channels | 2 | 2003 | 7 | 0.020 |
Why?
|
| Hibiscus | 1 | 2012 | 1 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 256 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 934 | 0.020 |
Why?
|
| Adolescent | 1 | 2003 | 6081 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 1772 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 314 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 735 | 0.020 |
Why?
|
| Exocytosis | 1 | 2006 | 49 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 5080 | 0.010 |
Why?
|
| Tunicamycin | 1 | 2004 | 21 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 51 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 52 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 127 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 154 | 0.010 |
Why?
|
| Cyclohexanols | 1 | 2003 | 11 | 0.010 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 2003 | 4 | 0.010 |
Why?
|
| Carbachol | 1 | 2003 | 18 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2003 | 13 | 0.010 |
Why?
|
| Receptors, Cannabinoid | 1 | 2003 | 31 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2003 | 10 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 22 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 256 | 0.010 |
Why?
|
| Nociceptors | 1 | 2003 | 30 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 97 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2003 | 73 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 139 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 165 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 137 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 94 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 462 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 532 | 0.010 |
Why?
|
| Pyrophosphatases | 1 | 2001 | 8 | 0.010 |
Why?
|
| U937 Cells | 1 | 2001 | 31 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2001 | 39 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 257 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 97 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 299 | 0.010 |
Why?
|
| Sodium | 1 | 2001 | 102 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 267 | 0.010 |
Why?
|
| Chickens | 1 | 2001 | 161 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 712 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 8214 | 0.010 |
Why?
|
| Fixatives | 1 | 1998 | 7 | 0.010 |
Why?
|
| Perfusion | 1 | 1998 | 38 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1998 | 31 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 460 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 42 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1070 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 945 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 283 | 0.010 |
Why?
|
| Polymers | 1 | 1998 | 155 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 12222 | 0.010 |
Why?
|
| Aging | 1 | 1998 | 783 | 0.010 |
Why?
|
| Neurons | 1 | 1998 | 1263 | 0.010 |
Why?
|